SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-018438
Filing Date
2016-11-14
Accepted
2016-11-14 16:03:53
Documents
63
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0916_yewbiopharm.htm 10-Q 805514
2 CERTIFICATION f10q0916ex31i_yewbiopharm.htm EX-31.1 10913
3 CERTIFICATION f10q0916ex31ii_yewbiopharm.htm EX-31.2 9984
4 CERTIFICATION f10q0916ex32_yewbiopharm.htm EX-32 4701
  Complete submission text file 0001213900-16-018438.txt   4233982

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20160930.xml EX-101.INS 831573
6 XBRL SCHEMA FILE yewb-20160930.xsd EX-101.SCH 50140
7 XBRL CALCULATION FILE yewb-20160930_cal.xml EX-101.CAL 47720
8 XBRL DEFINITION FILE yewb-20160930_def.xml EX-101.DEF 106780
9 XBRL LABEL FILE yewb-20160930_lab.xml EX-101.LAB 393116
10 XBRL PRESENTATION FILE yewb-20160930_pre.xml EX-101.PRE 246266
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 161994742
SIC: 0100 Agricultural Production-Crops